Sell RIM!: Against ...
Health Care: Drugs
Biopure Corporation Class A (BPUR: NASDAQ)
$0.08 0.00 | 0.00%
07/21/09 - 03:59 PM ET
TheStreet Ratings Grade for BPUR
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
Analyst Ratings data is not available for BPUR.
Portfolios with BPUR
- Portfolio NameUser Type
- Userodiex
- UserStart18
- UserAlycia's Speculative Stocks
- UserSony100
- UserFreshwater Portfolio 1
- Usermboomer17 Portfolio 1
- UserBubbaGUMPSmoney
- Usermcharyn Portfolio 1
- Userjohn.miller Portfolio 1
- Userjcm
Latest BPUR Headlines from TheStreet
- Biotech Stock Mailbag: Good Stocks Exist 06.12.09 | 08:06 am
- Biotech Stock Mailbag: HEB's Artful Dodging 06.05.09 | 07:06 am
- Northfield Blood Substitute Rejected by FDA 05.01.09 | 12:05 am
- Northfield, Polyheme Not Long for This World 03.18.09 | 12:03 am
- Ex-Biopure Exec Pleads Guilty To Faking Cancer 03.11.09 | 02:03 pm
- Blood Sub or Not, Northfield's a Negative 01.22.09 | 06:01 pm
- Biotech Notebook: Progenics, Wyeth, Introgen 04.30.08 | 09:04 am
- Feuerstein's Biotech-Stock Mailbag 03.29.08 | 12:03 pm
- Thursday's Small-Cap Winners & Losers 11.01.07 | 04:11 pm
- Northfield Botched Release of Safety Data 08.07.07 | 12:08 am
Press Releases for BPUR
Partner Headlines for BPUR
